S59 Adherence to nebulised therapies in people with cystic fibrosis starting Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
IntroductionCystic Fibrosis HealthHub (CFHH) is a digital platform in use by 17 adult CF centres in the UK which improves patient self-care by objectively monitoring adherence to nebulised therapies delivered via e-Track nebulisers which record device usage on a central server. This study aimed to o...
Gespeichert in:
Veröffentlicht in: | Thorax 2021-11, Vol.76 (Suppl 2), p.A40-A40 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!